Lupin 2024

FDA approves Zyvox generic from Glenmark

Print Friendly, PDF & Email

MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has been granted approval from the Food and Drug Administration for linezolid tablets 600 mg, an antibiotic.

Glenmark said its linezolid product is a therapeutic equivalent of Zyvox tablets 600 mg from Pfizer Inc.

Linezolid is indicated for the treatment of various types of bacterial infections, including pneumonia, skin infections and infections resistant to other antibiotics.

Zyvox tablets 600 mg had U.S. sales of $447.6 million for the 12 months through October, according to IMS Health data reported by Glenmark.


ECRM_06-01-22


Comments are closed.

Centrum 7/6  banner